Roger Crystal Opiant Pharmaceuticals, Inc. (OPNT) insider trading activity

Roger Crystal is Chief Executive Officer of OPIANT PHARMACEUTICALS, INC.. Currently has a direct ownership of 0 shares of OPNT, which is worth approximately $0. The most recent transaction as insider was on Mar 02, 2023, when has been sold 5,100 shares (Common Stock par value $0.001) at a price of $20.0 per share, resulting in proceeds of $102,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

ROGER CRYSTAL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 02 2023	SELL Sale (or disposition) back to the issuer	$102,000 $20.0 p/Share	5,100 Reduced 100.0%	0 Common Stock par value...
Mar 02 2023	SELL Sale (or disposition) back to the issuer	$1,640,120 $20.0 p/Share	82,006 Reduced 100.0%	0 Common Stock
Mar 02 2023	BUY Grant, award, or other acquisition	-	6,667 Added 50.0%	6,667 Common Stock
Jan 27 2023	SELL Open market or private sale	$27,513 $20.26 p/Share	1,358 Reduced 1.77%	75,339 Common Stock
Jan 09 2023	SELL Open market or private sale	$23,896 $20.2 p/Share	1,183 Reduced 1.52%	76,697 Common Stock
Jan 05 2023	SELL Open market or private sale	$101,585 $20.2 p/Share	5,029 Reduced 6.07%	77,880 Common Stock
Jul 14 2022	SELL Open market or private sale	$24,953 $11.11 p/Share	2,246 Reduced 2.64%	82,909 Common Stock

Jun 27 2022	BUY Grant, award, or other acquisition	-	6,667 Added 7.26%	85,155 Common Stock
Jan 27 2022	SELL Open market or private sale	$52,169 $26.15 p/Share	1,995 Reduced 2.48%	78,488 Common Stock
Jan 10 2022	SELL Open market or private sale	$32,258 $30.49 p/Share	1,058 Reduced 1.3%	80,483 Common Stock
Jan 04 2022	BUY Grant, award, or other acquisition	-	40,000 Added 32.91%	81,541 Common Stock
Sep 16 2021	BUY Open market or private purchase	$2,344 $23.44 p/Share	100 Added 1.92%	5,100 Common Stock par value...
Jan 26 2021	BUY Grant, award, or other acquisition	-	19,416 Added 31.85%	41,541 Common Stock

Also insider at

MNMD

Mind Medicine (MindMed) Inc. Healthcare

Roger Crystal

Chief Executive Officer

Santa Monica, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPNT shares.

Notify only if

Value

Insider Trading

Get notified when an Opiant Pharmaceuticals, Inc. insider buys or sells OPNT shares.

Notify only if

Operation

Value

Type

News

Receive news related to OPIANT PHARMACEUTICALS, INC.

Track Activities on OPNT

Account